Earnings History Data for Concert Pharmaceuticals, Inc. (CNCE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple tumors, and hyperparathyroidism. Concert Pharmaceuticals Inc. is based in United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2022	PM	7:00 AM ET (Nov 7)	CNCE	Concert Pharmaceuticals, Inc.	277.54	-0.58	-0.59	-0.78	Concert Pharma GAAP EPS of -$0.58 beats by $0.01, revenue of $0.08M in-line [11/7/2022 7:12 AM]	4.46	-1.11 (-20.02%)	5.30	-0.27 (-4.85%)	2.57 - 7.37	1,073,001	480,000	1,482
Concert Pharma GAAP EPS of -$0.58 beats by $0.01, revenue of $0.08M in-line [11/7/2022 7:12 AM] Concert Pharma falls 13% after third quarter results [11/7/2022 11:45 AM] Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-07-22 07:00AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	CNCE	Concert Pharmaceuticals, Inc.	208.11	-0.59	-0.96	0.16	Concert Pharma GAAP EPS of -$0.59 beats by $0.26, revenue of $0.02M misses by $0.06M [8/4/2022 7:09 AM]	6.20	0.20 (3.25%)	6.01	0.01 (0.17%)	2.57 - 6.88	1,072,964	580,000	1,748
Concert Pharma GAAP EPS of -$0.59 beats by $0.26, revenue of $0.02M misses by $0.06M [8/4/2022 7:09 AM]
05-05-2022	PM	6:00 AM ET (May 5)	CNCE	Concert Pharmaceuticals, Inc.	114.44	-1.00	-0.93	-0.67	Concert Pharma GAAP EPS of -$1.03 [5/5/2022 7:19 AM]	3.29	-0.23 (-6.53%)	0.0	0.0 (0.00%)	2.57 - 4.62	61,016	80,000	0
Concert Pharma Q1 2022 Earnings Preview [5/4/2022 1:29 PM] Concert Pharma GAAP EPS of -$1.03 [5/5/2022 7:19 AM] Concert Pharmaceuticals Reports First Quarter 2022 Financial Results [May-05-22 07:00AM] Concert Pharmaceuticals (CNCE) Reports Q1 Loss, Misses Revenue Estimates [May-05-22 08:45AM]
03-03-2022	PM	7:00 AM ET (Mar 3)	CNCE	Concert Pharmaceuticals, Inc.	103.98	-0.95	-0.76	-0.69	Concert Pharma GAAP EPS of -$1.01 misses by $0.24, revenue of $0.01M in-line [3/3/2022 6:04 AM]	2.95	-0.13 (-4.22%)	3.10	0.02 (0.65%)	2.57 - 6.93	27,031	100,000	1,269
Concert Pharma GAAP EPS of -$1.01 misses by $0.24, revenue of $0.01M in-line [3/3/2022 6:04 AM] Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update [Mar-03-22 06:00AM]
09-11-2021	PM	7:00 AM ET (Nov 9)	CNCE	Concert Pharmaceuticals, Inc.	118.08	-0.78	-0.76	-0.60	Concert Pharma EPS beats by $0.03, beats on revenue [11/9/2021 7:04 AM]	3.85	0.07 (1.72%)	3.64	-0.14 (-3.70%)	2.64 - 13.50	550,677	4,290,000	8,651
Concert Pharma Q3 2021 Earnings Preview [11/8/2021 11:54 AM] Concert Pharma EPS beats by $0.03, beats on revenue [11/9/2021 7:04 AM] Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update [Nov-09-21 07:00AM] Concert Pharmaceuticals (CNCE) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 08:15AM] Concert Pharmaceuticals, inc (CNCE) Q3 2021 Earnings Call Transcript [Nov-09-21 03:30PM]
05-08-2021	PM	7:00 AM ET (Aug 5)	CNCE	Concert Pharmaceuticals, Inc.	107.14	0.16	-0.72	-0.41	Concert Pharma EPS beats by $0.58, beats on revenue [8/5/2021 7:12 AM]	3.55	0.24 (7.25%)	3.60	0.29 (8.76%)	3.23 - 13.50	96,883	100,000	2,499
Concert Pharma EPS beats by $0.58, beats on revenue [8/5/2021 7:12 AM] Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results [Aug-05-21 07:00AM] Concert Pharmaceuticals, inc (CNCE) Q2 2021 Earnings Call Transcript [Aug-05-21 04:30PM]
04-05-2021	PM	7:00 AM ET (May 4)	CNCE	Concert Pharmaceuticals, Inc.	140.92	-0.67	-0.66	-0.70	Concert Pharma EPS beats by $0.02 [5/4/2021 7:20 AM]	3.87	-0.30 (-7.19%)	3.87	0.0 (0.00%)	3.86 - 13.50	443,958	270,000	780
Concert Pharma EPS beats by $0.02 [5/4/2021 7:20 AM] Concert Pharmaceuticals, Inc. to Host Earnings Call [May-04-21 06:45AM] Concert Pharmaceuticals Reports First Quarter 2021 Financial Results [May-04-21 07:00AM] Concert Pharmaceuticals (CNCE) Reports Q1 Loss, Lags Revenue Estimates [May-04-21 08:25AM] Concert Pharmaceuticals, Inc. (CNCE) Q1 2021 Earnings Call Transcript [May-04-21 01:00PM]
25-02-2021	PM	6:00 AM ET (Feb 25)	CNCE	Concert Pharmaceuticals, Inc.	216.69	-0.69	-0.73	-0.86	Concert Pharma EPS beats by $0.09 [2/25/2021 7:14 AM]	6.87	0.02 (0.29%)	7.05	0.20 (2.92%)	5.47 - 13.50	331,318	432,589	264
Concert Pharma EPS beats by $0.09 [2/25/2021 7:14 AM] Concert Pharmaceuticals Reports 2020 Financial Results and Provides Update on Clinical Programs [Feb-25-21 07:00AM] Concert Pharmaceuticals, Inc. to Host Earnings Call [Feb-25-21 06:30AM] We Think Concert Pharmaceuticals (NASDAQ:CNCE) Needs To Drive Business Growth Carefully [Feb-24-21 02:38AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	CNCE	Concert Pharmaceuticals, Inc.	281.35	-0.60	-0.68	-0.72	Concert Pharma EPS beats by $0.15 [11/5/2020 6:06 AM]	10.90	0.21 (1.96%)	10.90	0.0 (0.00%)	5.47 - 13.09	158,599	188,677	1,345

06-08-2020	PM	7:00 AM ET (Aug 6)	CNCE	Concert Pharmaceuticals, Inc.	282.30	-0.41	-0.68	-0.78	Concert Pharma EPS beats by $0.29, beats on revenue [8/6/2020 7:10 AM]	8.87	-0.69 (-7.22%)	9.56	0.0 (0.00%)	5.36 - 13.09	118,424	130,564	2,446